Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-7-7
pubmed:abstractText
Caspase-1 processes the interleukin (IL)-1beta and IL-18 inactive precursors to the biologically active cytokines that are known to have proatherogenic effects. The present study investigated the genetic variability of the CASP1 gene and plasma levels of caspase-1 in relation to cardiovascular risk. In Europeans, 3 tag SNPs captured 4 common haplotypes of the CASP1 gene. Among these, the A(in6) allele of the G+7/in6A polymorphism was less frequent in 246 cases with myocardial infarction and a parental history of disease than in 253 controls free of familial history of disease (0.13+/-0.02 versus 0.20+/-0.02; P=0.005). However, in a larger case/control study (n=1774), these effects are borderline restricted to the UK population. In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014). Baseline caspase-1 levels in the top quartile of the distribution were predictive of cardiovascular deaths (HR=3.62, 1.81 to 7.27; P=0.0003 compared with the bottom quartile). Finally, in vitro assays of allelic imbalance showed that the CASP1 haplotype carrying the A(in6) allele was associated with a lower mRNA expression. These results indicate that caspase-1 levels are predictive of future cardiovascular death in patients with coronary artery disease. The role of CASP1 genetic variations in the susceptibility to myocardial infarction requires further investigation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
7
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
102-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16778130-Adult, pubmed-meshheading:16778130-Aged, pubmed-meshheading:16778130-Cardiovascular Diseases, pubmed-meshheading:16778130-Case-Control Studies, pubmed-meshheading:16778130-Caspase 1, pubmed-meshheading:16778130-Cohort Studies, pubmed-meshheading:16778130-Coronary Artery Disease, pubmed-meshheading:16778130-Female, pubmed-meshheading:16778130-Follow-Up Studies, pubmed-meshheading:16778130-Gene Frequency, pubmed-meshheading:16778130-Genetic Predisposition to Disease, pubmed-meshheading:16778130-Genetic Variation, pubmed-meshheading:16778130-Genotype, pubmed-meshheading:16778130-Haplotypes, pubmed-meshheading:16778130-Humans, pubmed-meshheading:16778130-Interleukin-18, pubmed-meshheading:16778130-Male, pubmed-meshheading:16778130-Middle Aged, pubmed-meshheading:16778130-Myocardial Infarction, pubmed-meshheading:16778130-Polymorphism, Single Nucleotide, pubmed-meshheading:16778130-Prospective Studies, pubmed-meshheading:16778130-Risk Assessment
pubmed:year
2006
pubmed:articleTitle
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.
pubmed:affiliation
Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany. blankenberg@2-med.klinik.uni-mainz.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't